Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis

Heart ◽  
2020 ◽  
Vol 106 (24) ◽  
pp. 1878-1882
Author(s):  
Khawaja M Talha ◽  
Daniel C DeSimone ◽  
M Rizwan Sohail ◽  
Larry M Baddour

Infective endocarditis (IE) is uncommon and has, in the past, been most often caused by viridans group streptococci (VGS). Due to the indolent nature of these organisms, the phrase ‘subacute bacterial endocarditis’, so-called ‘SBE’, was routinely used as it characterised the clinical course of most patients that extended for weeks to months. However, in more recent years, there has been a significant shift in the microbiology of IE with the emergence of staphylococci as the most frequent pathogens, and for IE due to Staphylococcus aureus, the clinical course is acute and can be associated with sepsis. Moreover, increases in IE due to enterococci have occurred and have been characterised by treatment-related complications and worse outcomes. These changes in pathogen distribution have been attributed to a diversification in the target population at risk of IE. While prosthetic valve endocarditis and history of IE remain at highest risk of IE, the rise in prevalence of injection drug use, intracardiac device implantations and other healthcare exposures have heavily contributed to the existing pool of at-risk patients. This review focuses on common IE pathogens and their impact on the clinical profile of IE.

2017 ◽  
Vol 39 (7) ◽  
pp. 586-595 ◽  
Author(s):  
Martin H Thornhill ◽  
Simon Jones ◽  
Bernard Prendergast ◽  
Larry M Baddour ◽  
John B Chambers ◽  
...  

Abstract Aims There are scant comparative data quantifying the risk of infective endocarditis (IE) and associated mortality in individuals with predisposing cardiac conditions. Methods and results English hospital admissions for conditions associated with increased IE risk were followed for 5 years to quantify subsequent IE admissions. The 5-year risk of IE or dying during an IE admission was calculated for each condition and compared with the entire English population as a control. Infective endocarditis incidence in the English population was 36.2/million/year. In comparison, patients with a previous history of IE had the highest risk of recurrence or dying during an IE admission [odds ratio (OR) 266 and 215, respectively]. These risks were also high in patients with prosthetic valves (OR 70 and 62) and previous valve repair (OR 77 and 60). Patients with congenital valve anomalies (currently considered ‘moderate risk’) had similar levels of risk (OR 66 and 57) and risks in other ‘moderate-risk’ conditions were not much lower. Congenital heart conditions (CHCs) repaired with prosthetic material (currently considered ‘high risk’ for 6 months following surgery) had lower risk than all ‘moderate-risk’ conditions—even in the first 6 months. Infective endocarditis risk was also significant in patients with cardiovascular implantable electronic devices. Conclusion These data confirm the high IE risk of patients with a history of previous IE, valve replacement, or repair. However, IE risk in some ‘moderate-risk’ patients was similar to that of several ‘high-risk’ conditions and higher than repaired CHC. Guidelines for the risk stratification of conditions predisposing to IE may require re-evaluation.


2019 ◽  
Vol 13 (02) ◽  
pp. 93-100 ◽  
Author(s):  
Arman Vahabi ◽  
Funda Gül ◽  
Sabina Garakhanova ◽  
Hilal Sipahi ◽  
Oğuz Reşat Sipahi

Introduction: Despite developments in medicine, infective endocarditis (IE) is still associated with significant morbidity and mortality. In this study it was aimed to systematically review the infective endocarditis literature published or presented from Turkey. Methods: To find the published series, one national database (Ulakbim), and three international databases (Scopus, Pubmed and Sci-e) were searched between 31 October-3 November 2014. also, abstracts of congresses by three national congresses were searched for studies regarding infective endocarditis. Results: Data for 1270 patients (38.3% female, mean age 46.2, 28% prosthetic valve endocarditis) with a diagnosis of infective endocarditis were obtained from 21 reports (18 published articles and three congress abstracts). Of the 18 articles, four were in peer-reviewed medical journals indexed in national databases and 14 were in international databases. There was an underlying heart disease in 51.9% and history of dental procedure was 6.7%. Fever, heart murmur and fatigue were present in 94%, 71.4% and 69% respectively. most commonly involved site was mitral valve (43.3%), followed by aortic (33.8%) and tricuspid valve (6.4%). Staphylococcus aureus, coagulase-negative staphylococci and enterococci comprised the 22.8%, 9.7% and 7.5% of the cases while 31.1% were culture-negative. Overall mortality was 23.4%. When we compared series related to years 2008 and before and 2009 and after, the mortality rates were (24.1%-224/931) vs (20.1%-32/159), respectively (p = 0,31). Conclusion: Infective endocarditis is still associated with significant mortality. S. aureus seems to be the most common etiologic agent. There was a slight decrease in the recent years in mortality.


2019 ◽  
Vol 2019 ◽  
pp. 1-4 ◽  
Author(s):  
Aniket S. Rali ◽  
Mejalli Al-Kofahi ◽  
Nilay Patel ◽  
Benjamin Wiele ◽  
Zubair Shah ◽  
...  

Over the past five decades, the incidence of intravenous drug use- (IVDU-) associated infective endocarditis (IE) has been on the rise in North America. Classically, IVDU has been thought to affect right-sided valves. However, in recent times a more variable presentation of IVDU-associated IE has been reported. Here, we report a case of a patient with a known history of IVDU who presented with clinical symptoms concerning for right- as well as left-sided endocarditis. In addition, we also discuss what should be considered adequate evaluation for patients with suspected endocarditis, and more specifically, what should be the role of transesophageal echocardiography in patients with IE noted on transthoracic echocardiography.


2021 ◽  
Vol 14 (9) ◽  
pp. e244191
Author(s):  
Gautam Sen ◽  
Susan Lewis

Infective endocarditis remains a dangerous condition and carries a mortality risk of approximately 20%. Splenic rupture is a rare complication of endocarditis. A 60-year-old woman with a history of atrial fibrillation, mitral valve repair and severe mitral regurgitation was admitted with a fall and abdominal pain. Emergency laparotomy was performed leading to a diagnosis of splenic rupture, for which splenectomy was performed. Four months later, the patient represented with symptoms of a transient ischaemic attack. Transthoracic and transoesophageal echocardiogram confirmed a large vegetation on the anterior mitral valve leaflet. Treatment with antibiotics and re-do mitral valve surgery was performed. The cause of the initial splenic rupture was felt to have been secondary to undiagnosed infective endocarditis. It is imperative to consider endocarditis in a case of spontaneous splenic rupture particularly in high-risk patients such as those with previous valve surgery.


Traditio ◽  
1954 ◽  
Vol 10 ◽  
pp. 594-625 ◽  
Author(s):  
Brian Tierney

During the past decade there has been a significant shift of emphasis in work on the medieval canonists. The traditional studies on the literary history of canonistic sources and on problems of specifically ecclesiastical jurisprudence continue to flourish, and, indeed, have been stimulated by the plans for a new edition of Gratian's Decretum; but alongside this work, and complementary to it, there has appeared a new trend, a lively interest in the content and influence of canonistic doctrine concerning public law and political theory. This trend, moreover, shows all the international diffusion — and even, perhaps, something of the interplay of national susceptibilities — that its exponents have discerned in the work of the medieval canonists themselves. It is especially interesting that notable contributions have come from England and the United States as well as from the more established centers of canonistic studies.


2014 ◽  
Vol 2014 ◽  
pp. 1-3
Author(s):  
Mazen E. Iskandar ◽  
Michael G. Wayne ◽  
Justin G. Steele ◽  
Avram M. Cooperman

At-risk family members with familial pancreatic cancer (FCaP) face uncertainty regarding the individual risk of developing pancreatic cancer (CaP) and whether to choose serial screening or prophylactic pancreatectomy to avoid CaP. We treated 2 at-risk siblings with a history of FCaP, congenital hepatic fibrosis (CHF), and jaundice secondary to a bile duct stricture. In one, a pancreaticoduodenal resection was done and in the second a total pancreatectomy. Malignancy was not present, but extensive pancreatic intraepithelial neoplasia (PanIn) 2 was present throughout both pancreata. The clinical course and literature review are presented along with the previously unreported association of CHF and CaP.


2014 ◽  
Vol 34 (7) ◽  
pp. 766-774 ◽  
Author(s):  
Masaaki Nakayama ◽  
Masanobu Miyazaki ◽  
Kazuho Honda ◽  
Kenji Kasai ◽  
Tadashi Tomo ◽  
...  

IntroductionEncapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD). Over the past decade in Japan, a multidisciplinary approach has been adopted to minimize the incidence and improve outcomes of EPS. This strategy includes planned PD discontinuation for high-risk patients and the introduction of biocompatible solutions. This study examined the current clinical status of EPS in representative PD centers in Japan.Design, setting, participants and measurementsPatients ( n = 1,338) from 55 PD centers in Japan who were using neutral-pH solutions from the initiation of therapy (mean age, 62 years; median PD duration, 32 months; concomitant use of icodextrin, 35.2%; PD and hemodialysis combination therapy, 12.2%) were assessed every 6 months to ascertain the reasons for PD discontinuation and the development of EPS development. Outcomes were also recorded. The study period was from November 2008 to March 2012.ResultsThere were 727 patients who discontinued PD, including 163 deaths. Among all causes of PD withdrawal except for death, planned PD discontinuation to avoid EPS was utilized in 58 cases (7.1% in total). The strategy was increasingly utilized in proportion to the duration of PD: 0.5% for patients undergoing PD for < 3 years, 0.6% for patients undergoing PD for 5 years, 14.7% for patients undergoing PD for 8 years, and 35.5% for patients undergoing PD for > 8 years. Fourteen patients developed EPS (three cases after PD), which corresponded with an overall incidence of 1.0%. The incidence according to the duration of PD was 0.3% for PD < 3 years, 0.6% for PD = 5 years, 2.3% for PD = 8 years, and 1.2% for PD > 8 years. In terms of therapy, 11 patients were treated with prednisolone (PSL), and surgical enterolysis was utilized in two cases. Complete remission of abdominal symptoms was achieved in twelve patients (85.7%), and three died due to EPS (mortality rate of 21.4%).ConclusionsUse of the multidisciplinary approach described above reduces the risk of the development of EPS according to PD duration. In cases of de novo EPS cases in Japan, this strategy can also attenuate the clinical course of the condition.


2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1750.1-1750
Author(s):  
M. Aghaei ◽  
S. Sedighi ◽  
M. Hassani ◽  
M. R. Damirchi

Background:Osteoporosis is a common rheumatologic disorder in postmenopausal women which could lead to morbidities later in life. However, this condition has not been properly studied in premonapausal women.During pregnancy, the fetus needs a total of 30 grams of calcium for its skeleton and during lactation, 200 mg of calcium is secreted in the breast milk per day which the mother acquires by doubling its intestinal absorption rate. If the calcium intake of the mother is not sufficient to satisfy the fetus’ needs, it will be provided by bone resorption, which will decrease the maternal calcium reserves [1].Pregnancy and Lactation Associated Osteoporosis (PLAO) is a rare condition associated with pregnancy that should be considered in premenopausal women. The most commonly affected sites are the vertebrae and, more rarely, the hips, pubic rami and ribs [2].An important complication of osteoporosis is fracture and a preemptive diagnosis and treatment thereof, can have drastic effects on the quality of life.Objectives:Our objective is to document the relevant risk factors, present signs and symptoms, course of illness, and response to treatment in three cases of PLAO. It is quite possible that osteoporosis in pregnancyand lactation is more frequent than recognized, simply because it is only recognized when an-unexpected fracture occurs[3]. Thus, in this article we are presenting three cases that showcase the need for more rigorous research on PLAO risk factors, the need for screening in high risk patients, and the advantages of early detection in patients’ outcome.Methods:The clinical cases of the patients whose PLAO diagnoses had been confirmed by both a radiologist and a rheumatologist in the past year was extracted. Information related to demographic indices, clinical manifestations, and the treatment methods was evaluated and compared.Results:In the past year, three patients with a chief complaint of low-back pain have visited our clinic. The first, a 22-year-old woman with a nursing history of 2 months, the next one, a 31-year-old woman with a nursing history of 3 months, and the last, a 22-year-old woman with a nursing history of 4 months. All three patients had low back pain and tenderness. Two out of three patients had deficient vitamin D levels and the other had a normal one. All three patients had low BMD in lumbar vertebra and MRI imagings indicative of osteoporotic fracture.Table 1.General and pregnancy-relatedcharacteristics of the case studiesVariablesCase 1Case 2Case 3Age223122Nursing duration2 months3months4monthsBMD(lumbar spine)-3.6-3.5-3.1Vitamin D level12.6(ng/ml)31.6(ng/ml)8(ng/ml)FractureT12,L1T4,5,6,7,10,L2L1,2,3,4,5Conclusion:Since the symptoms of PLAO are often confused with pain in other low-back pain conditions associated with pregnancy, PLAO is a mostly overlooked diagnosis[4]. It is only recognized when an unexpected fracture occurs [3]Therefore, high risk patients with less severe symptoms are usually not diagnosed and thusly, should undergo a proper screening test, so that they are recognized early and the morbid sequelae are averted.References:[1]Kovacs, C. S., and S. H. Ralston. “Presentation and Management of Osteoporosis Presenting in Association with Pregnancy or Lactation.”Osteoporosis International, vol. 26, no. 9, 2015, pp. 2223–2241., doi:10.1007/s00198-015-3149-3.[2]Gregorio, Silvana Di, et al. “Osteoporosis with Vertebral Fractures Associated with Pregnancy and Lactation.”Nutrition, vol. 16, no. 11-12, 2000, pp. 1052–1055., doi:10.1016/s0899-9007(00)00430-5.[3]Bartl, Reiner, and Christoph Bartl. “The Osteoporosis Manual.” 2019, doi:10.1007/978-3-030-00731-7.[4]Eroglu, Semra, et al. “Evaluation of Bone Mineral Density and Its Associated Factors in Postpartum Women.”Taiwanese Journal of Obstetrics and Gynecology, vol. 58, no. 6, 2019, pp. 801–804., doi:10.1016/j.tjog.2019.09.013.Disclosure of Interests:None declared


2009 ◽  
Vol 75 (6) ◽  
pp. 470-476 ◽  
Author(s):  
Jitesh A. Patel ◽  
Nilesh A. Patel ◽  
Greta L. Piper ◽  
Deane E. Smith ◽  
Gautum Malhotra ◽  
...  

Obesity and rapid weight loss after bariatric surgery is associated with the development of cholelithiasis and related complications. Several algorithms have been suggested in the management of the asymptomatic gallstones in patients presenting for weight loss surgery (WLS). Charts of patients presenting for laparoscopic Roux-en-Y (LRYGB) were retrospectively reviewed. Concomitant or delayed cholecystectomies were performed for symptomatic disease at the time of or after LRYGB, respectively. A total of 1376 patients underwent LRYGB and 21.0 per cent had a history of a cholecystectomy. An additional 2.7 per cent underwent cholecystectomy. The remaining 1050 “at-risk” patients were followed for a mean of 32.3 months and 4.9 per cent underwent delayed cholecystectomy for symptomatic disease. Of these patients, 88.5 per cent presented within 2 years of LRYGB. No significant morbidities were experienced by the “at-risk” cohort. Currently, there is no consensus in the treatment of asymptomatic cholelithiasis in patients presenting for WLS. A conservative regimen of reserving cholecystectomy for symptomatic disease is safe in patients undergoing LRYGB. Subsequent cholecystectomy was required in 4.9% with the majority of these patients presenting within 2 years of LRYGB. Further investigations in the form of randomized, prospective studies are necessary to clearly define the indications for cholecystectomy at the time of WLS.


Sign in / Sign up

Export Citation Format

Share Document